Pharmacokinetics Services Market Size & Share - Growth Forecast Report (2026-2035)

Industry Insight by study phase, preclinical services accounted for approximately 35% of the market in 2025, reflecting the need to establish exposure, dose-response relationships, and drug-disposition characteristics before progression into human studies. (Aragen Life Sciences Ltd, Charles River Laboratories International Inc, Certara Inc, Evotec SE, Eurofins Scientific SE, Frontage Laboratories Inc, ICON plc, Parexel International Corporation, SGS Société Générale de Surveillance SA, Thermo Fisher Scientific Inc), by Service Type (Preclinical PK Services, Clinical PK Services, Bioanalytical Services, Consulting & Modeling Services, Regulatory Support Services), by Drug Type (Small Molecules, Large Molecules), by Study Phase (Discovery, Preclinical, Clinical Phase I–III, Post-Approval & Lifecycle Management), by End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Government Research Institutes, Other End Users)